Literature DB >> 8675629

Impaired activity and gene expression of hexokinase II in muscle from non-insulin-dependent diabetes mellitus patients.

H Vestergaard1, C Bjørbaek, T Hansen, F S Larsen, D K Granner, O Pedersen.   

Abstract

After entering the muscle cell, glucose is immediately and irreversibly phosphorylated to glucose-6-phosphate by hexokinases (HK) I and II. Previous studies in rodents have shown that HKII may be the dominant HK in skeletal muscle. Reduced insulin-stimulated glucose uptake and reduced glucose-6-phosphate concentrations in muscle have been found in non-insulin-dependent diabetes mellitus (NIDDM) patients when examined during a hyperglycemic hyperinsulinemic clamp. These findings [correction of finding] are consistent with a defect in glucose transport and/or phosphorylation. In the present study comprising 29 NIDDM patients and 25 matched controls, we tested the hypothesis that HKII activity and gene expression are impaired in vastus lateralis muscle of NIDDM patients when examined in the fasting state. HKII activity in a supernatant of muscle extract accounted for 28 +/- 5% in NIDDM patients and 40 +/- 5% in controls (P = 0.08) of total muscle HK activity when measured at a glucose media of 0.11 mmol/liter and 31 +/- 4 and 47 +/- 7% (P = 0.02) when measured at 0.11 mmol/liter of glucose. HKII mRNA, HKII immunoreactive protein level, and HKII activity were significantly decreased in NIDDM patients (P < 0.0001, P = 0.03, and P = 0.02, respectively) together with significantly decreased glycogen synthase mRNA level and total glycogen synthase activity (P = 0.02 and P = 0.02, respectively). In the entire study population HKII activity estimated at 0.11 and 11.0 mM glucose was inversely correlated with fasting plasma glucose concentrations (r = -0.45, P = 0.004; r = -0.54, P < 0.0001, respectively) and fasting plasma nonesterified fatty acid concentrations (r = -0.46, P = 0.003; r = -0.37, P = 0.02, respectively). In conclusion, NIDDM patients are characterized by a reduced activity and a reduced gene expression of HKII in muscle which may be secondary to the metabolic peturbations. HKII contributes with about one-third of total HK activity in a supernatant of human vastus lateralis muscle.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8675629      PMCID: PMC185969          DOI: 10.1172/JCI118329

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

1.  The molecular mechanism by which insulin stimulates glycogen synthesis in mammalian skeletal muscle.

Authors:  P Dent; A Lavoinne; S Nakielny; F B Caudwell; P Watt; P Cohen
Journal:  Nature       Date:  1990-11-22       Impact factor: 49.962

2.  Substrate specific activation by glucose 6-phosphate of the dephosphorylation of muscle glycogen synthase.

Authors:  C Villar-Palasi
Journal:  Biochim Biophys Acta       Date:  1991-11-12

3.  Exercise-enhanced activation of glycogen synthase in human skeletal muscle.

Authors:  J F Bak; O Pedersen
Journal:  Am J Physiol       Date:  1990-06

4.  31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate. Evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitus.

Authors:  D L Rothman; R G Shulman; G I Shulman
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

5.  Fasting hyperglycemia normalizes oxidative and nonoxidative pathways of insulin-stimulated glucose metabolism in noninsulin-dependent diabetes mellitus.

Authors:  L J Mandarino; A Consoli; D E Kelley; J J Reilly; N Nurjhan
Journal:  J Clin Endocrinol Metab       Date:  1990-12       Impact factor: 5.958

6.  Glucose-6-phosphate stimulation of human muscle glycogen synthase phosphatase.

Authors:  M Okubo; C Bogardus; S Lillioja; D M Mott
Journal:  Metabolism       Date:  1988-12       Impact factor: 8.694

7.  Hyperglycaemia compensates for the defects in insulin-mediated glucose metabolism and in the activation of glycogen synthase in the skeletal muscle of patients with type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  A Vaag; P Damsbo; O Hother-Nielsen; H Beck-Nielsen
Journal:  Diabetologia       Date:  1992-01       Impact factor: 10.122

8.  Insulin resistance in type 2 (non-insulin-dependent) diabetic patients and their relatives is not associated with a defect in the expression of the insulin-responsive glucose transporter (GLUT-4) gene in human skeletal muscle.

Authors:  J Eriksson; L Koranyi; R Bourey; C Schalin-Jäntti; E Widén; M Mueckler; A M Permutt; L C Groop
Journal:  Diabetologia       Date:  1992-02       Impact factor: 10.122

9.  Impaired expression of glycogen synthase mRNA in skeletal muscle of NIDDM patients.

Authors:  H Vestergaard; C Bjørbaek; P H Andersen; J F Bak; O Pedersen
Journal:  Diabetes       Date:  1991-12       Impact factor: 9.461

10.  Decreased insulin-stimulated 3-0-methylglucose transport in in vitro incubated muscle strips from type II diabetic subjects.

Authors:  K Andréasson; D Galuska; A Thörne; T Sonnenfeld; H Wallberg-Henriksson
Journal:  Acta Physiol Scand       Date:  1991-06
View more
  18 in total

1.  Acute regulation by insulin of phosphatidylinositol-3-kinase, Rad, Glut 4, and lipoprotein lipase mRNA levels in human muscle.

Authors:  M Laville; D Auboeuf; Y Khalfallah; N Vega; J P Riou; H Vidal
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

2.  The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetes.

Authors:  G D Tan; B A Fielding; J M Currie; S M Humphreys; M Désage; K N Frayn; M Laville; H Vidal; F Karpe
Journal:  Diabetologia       Date:  2004-12-24       Impact factor: 10.122

3.  Overexpression of hexokinase 2 reduces mitochondrial calcium overload in coronary endothelial cells of type 2 diabetic mice.

Authors:  Minglin Pan; Ying Han; Aninda Basu; Anzhi Dai; Rui Si; Conor Willson; Angela Balistrieri; Brian T Scott; Ayako Makino
Journal:  Am J Physiol Cell Physiol       Date:  2018-03-07       Impact factor: 4.249

4.  Serine/threonine protein kinase 25 (STK25): a novel negative regulator of lipid and glucose metabolism in rodent and human skeletal muscle.

Authors:  A Nerstedt; E Cansby; C X Andersson; M Laakso; A Stančáková; M Blüher; U Smith; M Mahlapuu
Journal:  Diabetologia       Date:  2012-03-04       Impact factor: 10.122

5.  Expression of the splice variants of the p85alpha regulatory subunit of phosphoinositide 3-kinase in muscle and adipose tissue of healthy subjects and type 2 diabetic patients.

Authors:  E Lefai; M Roques; N Vega; M Laville; H Vidal
Journal:  Biochem J       Date:  2001-11-15       Impact factor: 3.857

6.  Impaired insulin-induced site-specific phosphorylation of TBC1 domain family, member 4 (TBC1D4) in skeletal muscle of type 2 diabetes patients is restored by endurance exercise-training.

Authors:  B F Vind; C Pehmøller; J T Treebak; J B Birk; M Hey-Mogensen; H Beck-Nielsen; J R Zierath; J F P Wojtaszewski; K Højlund
Journal:  Diabetologia       Date:  2010-10-13       Impact factor: 10.122

7.  Gene expression in skeletal muscle biopsies from people with type 2 diabetes and relatives: differential regulation of insulin signaling pathways.

Authors:  Jane Palsgaard; Charlotte Brøns; Martin Friedrichsen; Helena Dominguez; Maja Jensen; Heidi Storgaard; Camilla Spohr; Christian Torp-Pedersen; Rehannah Borup; Pierre De Meyts; Allan Vaag
Journal:  PLoS One       Date:  2009-08-11       Impact factor: 3.240

8.  Coordinated patterns of gene expression for substrate and energy metabolism in skeletal muscle of diabetic mice.

Authors:  Vijay K Yechoor; Mary-Elizabeth Patti; Robert Saccone; C Ronald Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-29       Impact factor: 11.205

9.  Expression of key genes of fatty acid oxidation, including adiponectin receptors, in skeletal muscle of Type 2 diabetic patients.

Authors:  C Debard; M Laville; V Berbe; E Loizon; C Guillet; B Morio-Liondore; Y Boirie; H Vidal
Journal:  Diabetologia       Date:  2004-05-01       Impact factor: 10.122

10.  Spiroscytalin, a new tetramic acid and other metabolites of mixed biogenesis from Scytalidium cuboideum.

Authors:  Arlene A Sy-Cordero; Mario Figueroa; Huzefa A Raja; Maria Elena Meza Aviña; Mitchell P Croatt; Audrey F Adcock; David J Kroll; Mansukh C Wani; Cedric J Pearce; Nicholas H Oberlies
Journal:  Tetrahedron       Date:  2015-11-25       Impact factor: 2.457

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.